CU BO CURCUMIN BOSWELLIA
Live / Registered — Registered (as of 16 Sept 2025)
What this means for you
Registered since 16 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79381593
- Registration number
- 7942998
- Mark type
- Design + words
- Filed
- 08 Sept 2023
- Published for opposition
- 29 Jul 2025
- Registered
- 16 Sept 2025
- Attorney of record
- Robert S. Broder
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of pharmaceuticals for treating of gastrointestinal diseases, abdominal bloating, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome, dietary supplements and dietetic preparations, all containing curcumin and boswellia; Chemical preparations for the manufacture of pharmaceuticals, dietary supplements and dietetic preparations, for treating of gastrointestinal diseases, abdominal bloating, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome, all containing curcumin and boswellia; Chemical additives for use in the manufacture of food, all containing curcumin and boswellia.
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of gastrointestinal diseases, abdominal bloating, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome diseases, all containing curcumin and boswellia; dietary supplements and dietetic preparations, all containing curcumin and boswellia; Plant and herb extracts, other than essential oils, for medicinal purposes, all containing curcumin and boswellia.
Owner
- INDENA S.p.A, IT
- INDENA S.p.A, IT
- INDENA S.p.A, IT
Prosecution history
- 27 Mar 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 27 Mar 2026 — FINAL DISPOSITION PROCESSED
- 16 Dec 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 16 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
- 29 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Jul 2025 — PUBLISHED FOR OPPOSITION
- 23 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 May 2025 — REFUSAL PROCESSED BY IB
- 15 Apr 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 15 Apr 2025 — REFUSAL PROCESSED BY MPU